White Papers - McKesson Canada
Is Canada Ready to Immunize its Population Against COVID-19?
With COVID-19 vaccines hopefully becoming available within a few months, are we ready as a country to immunize 37 million Canadians? This white paper examines how community pharmacy, which already plays a huge role in seasonal flu immunizations, can partner with governments to deliver a successful mass immunization program with the combination of trained healthcare professionals, geographic reach, and tools to ensure compliance with multi-dose inoculation regimens. Recommendations are also provided to ensure pharmacy readiness to support the largest immunization program in Canadian history.
Is Canada’s Drug Supply Ready for Wave 2 of COVID-19?
Canada’s drug supply came under considerable strain during COVID-19, requiring the implementation of broad-based measures to prevent widespread drug shortages. Now, as COVID-19 case counts rise across the country, is Canada’s drug supply ready for wave 2? This white paper examines the lessons learned from the first wave, the preparations made by McKesson Canada and pharmaceutical distributors for wave 2, and recommendations to further strengthen Canada’s drug supply.
Is Canada’s Supply Chain Ready for a COVID-19 Vaccine?
Distributing a COVID-19 vaccine to 37 million Canadians will be a huge task that will be part of the largest public health distribution effort in human history. McKesson Canada authored a thoughtful discussion paper intended to be a resource as we collectively consider the distribution model of a future COVID-19 Vaccine.